Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context

NCT04407923 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT04407923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04407923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Unknown status
Start date
May 25, 2020
Completion date
November 25, 2020
Enrollment
150 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19, juvenile idiopathic arthritis, treatment